Mumbai, Jan. 27 -- The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.

The facility is an extension of the company's US FDA approved plant that is already supplying to the U.S., Europe, Japan and many other markets.

The Niacinamide from the new plant in addition to its various applications in skin and hair care, will also pave way for the company to foray into infant nutrition market globally, with food grade Niacin.

The production of these new grades of Vitamin B3 will significantly enhance the company's presence within value-added products with this high-value and high-margin offering.

Deepak Jain, CEO & managing director, Jubilant Ingre...